Bordeaux Population Health Research Center (BPH) - UMR 1219: Recent submissions
Now showing items 4141-4160 of 4357
-
Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa
(Liver international. vol. 39, n° 2, pp. 280-289, 2019)Article de revue -
Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan Africa
(Transactions of The Royal Society of Tropical Medicine and Hygiene. vol. 113, n° 8, pp. 437-445, 2019)Article de revue -
Impact of a prenatal episode and diagnosis in women with serious mental illnesses on neonatal complications (prematurity, low birth weight, and hospitalization in neonatal intensive care units)
(Archives of Women's Mental Health. vol. 22, n° 4, pp. 439-446, 2019)Article de revue -
An Insight into Biological datamining based on Rarity and Correlation as Constraints
(Proceedings of the 34th ACM/SIGAPP Symposium on Applied Computing, Proceedings of the ACM Symposium on Applied Computing, cy, Limassol, 2019)Autre communication scientifique (congrès sans actes - poster - séminaire...) -
Data-driven adult asthma phenotypes based on clinical characteristics are associated with asthma outcomes twenty years later
(Allergy. vol. 74, n° 5, pp. 953-963, 2019)Article de revue -
Safety of levonorgestrel 52mg intrauterine system compared to copper intrauterine device: a population-based cohort study
(Contraception. vol. 99, n° 6, pp. 345-349, 2019)Article de revue -
A systematic review of complementary and alternative medicine in oncology: Psychological and physical effects of manipulative and body-based practices
(PLoS ONE. vol. 14, n° 10, pp. e0223564, 2019)Article de revueOpen access -
Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review
(Critical Reviews in Oncology/Hematology. vol. 137, pp. 35-42, 2019)Article de revueOpen access -
Neurologic manifestations of elderly patients with cancer
(Aging Clinical and Experimental Research. vol. 31, n° 2, pp. 201-207, 2019)Article de revue -
Poor adherence to population-based vaccination in two counties after meningococcal B:14:P1.7,16 outbreak: an illustration of the growing vaccine hesitancy in France
(Archives de Pédiatrie. vol. 26, n° 2, pp. 75-79, 2019)Article de revue -
Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults
(Age and Ageing. vol. 48, n° 5, pp. 696-702, 2019)Article de revue -
The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data
(International journal for equity in health. vol. 18, n° 1, pp. 189, 2019)Article de revueOpen access -
Post-stroke pathway analysis and link with one year sequelae in a French cohort of stroke patients: the PAPASePA protocol study
(BMC Health Services Research. vol. 19, n° 1, pp. 770, 2019)Article de revueOpen access -
Dissimilarities across age groups in the associations between complementary feeding practices and child growth: Evidence from rural Togo
(Maternal & Child Nutrition. vol. 15, n° 4, pp. e12843, 2019)Article de revue -
Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry
(Pediatric Nephrology. vol. 34, n° 4, pp. 713-721, 2019)Article de revueOpen access -
Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study
(Pharmacological Research. vol. 141, pp. 201-207, 2019)Article de revue -
Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation
(Stroke. vol. 50, n° 9, pp. 2469-2476, 2019)Article de revueOpen access -
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation
(Clinical Pharmacology and Therapeutics. vol. 105, n° 6, pp. 1439-1455, 2019)Article de revue -
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation
(British Journal of Clinical Pharmacology. vol. 85, n° 2, pp. 432-441, 2019)Article de revue -
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database
(Atherosclerosis. vol. 281, pp. 98-106, 2019)Article de revue